What does Presscuff do?

Presscuff is registered with the CBE as active in: Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden. Private Limited, started on 4 April 2023, 1 establishment.

What is the address of Presscuff?

The registered office of Presscuff is located at Agoralaan Abis, 3590 Diepenbeek.

Is Presscuff still active?

Yes. According to the CBE (31 October 2026) Presscuff is active, legal situation “Normale toestand”, started on 4 April 2023.

Is Presscuff registered on Peppol?

Yes, Presscuff is registered on the Peppol network with ID 0208:0800361153.

What is the enterprise number of Presscuff?

The enterprise number of Presscuff is BE0800361153.

When was Presscuff founded?

Presscuff was founded on 4 April 2023.

Who are the directors of Presscuff?

According to the 2026 annual accounts, the directors of Presscuff are: SureFinance BV, Mabeco BV, Emiel Suijs.

Is Presscuff a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 April 2023; 3 annual accounts filed, latest fiscal year 2026; 3 directors known from the annual account.

How much profit did Presscuff make in 2026?

Presscuff recorded a loss after taxes of € 88,591 in financial year 2026.

What is the revenue of Presscuff?

As a small company, Presscuff is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € -77,588.

Does Presscuff have a website?

Yes, Presscuff has a website at presscuff.com.

Presscuff (Private Limited) - Diepenbeek - BE0800361153

Dossier Presscuff, printed on 31 October 2026 from databakkes.be/en/0800361153/presscuff. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2025 and 2026.
Board fully replaced NBB

No director from three years ago is still active according to annual account 2026.
Busy address KBO

14 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2026

Presscuff from Diepenbeek, company number BE0800361153, closed financial year 2026 with a result of € -88,591 after tax. For that financial year Presscuff recorded a gross margin of € -77,588 and equity of € 443,659. Compared with financial year 2025, the result moved from € -24,105 to € -88,591. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 23, 2026.

What it is worth Growing

€ 443,659

▲ 184% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -88,591

▼ 268 % more loss than in 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 452,782

▲ 197% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -123,841.

Debts at end 2026

Bank debt

€ 61,667

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 8,923

▼ 32% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2024	2025	2026	Change 2025 → 2026
Gross margin	€ -10,894 Gross margin 2024: € -10,894 First fiscal year in the series	€ -22,516 Gross margin 2025: € -22,516 ▼ € 11,622 vs 2024 (€ -10,894) Unfavourable step	€ -77,588 Gross margin 2026: € -77,588 ▼ € 55,072 vs 2025 (€ -22,516) Unfavourable step	▼ € 55,072
Profit after taxes	€ -11,145 Profit after taxes 2024: € -11,145 First fiscal year in the series	€ -24,105 Profit after taxes 2025: € -24,105 ▼ € 12,960 vs 2024 (€ -11,145) Unfavourable step	€ -88,591 Profit after taxes 2026: € -88,591 ▼ € 64,486 vs 2025 (€ -24,105) Unfavourable step	▼ € 64,486
Equity	€ 19,855 Equity 2024: € 19,855 First fiscal year in the series	€ 156,251 Equity 2025: € 156,251 ▲ € 136,395 vs 2024 (€ 19,855) Favourable step	€ 443,659 Equity 2026: € 443,659 ▲ 184% vs 2025 (€ 156,251) Favourable step	▲ 184%
Total debts	€ 10,280 Total debts 2024: € 10,280 First fiscal year in the series	€ 13,028 Total debts 2025: € 13,028 ▲ 27% vs 2024 (€ 10,280) Unfavourable step	€ 71,502 Total debts 2026: € 71,502 ▲ € 58,474 vs 2025 (€ 13,028) Unfavourable step	▲ € 58,474
Cash	€ 21,189 Cash 2024: € 21,189 First fiscal year in the series	€ 152,422 Cash 2025: € 152,422 ▲ € 131,234 vs 2024 (€ 21,189) Favourable step	€ 452,782 Cash 2026: € 452,782 ▲ 197% vs 2025 (€ 152,422) Favourable step	▲ 197%
Retained profit	€ -11,145 Retained profit 2024: € -11,145 First fiscal year in the series	€ -35,249 Retained profit 2025: € -35,249 ▼ € 24,105 vs 2024 (€ -11,145) Unfavourable step	€ -123,841 Retained profit 2026: € -123,841 ▼ € 88,591 vs 2025 (€ -35,249) Unfavourable step	▼ € 88,591
Bank debt	€ 0 Bank debt 2024: € 0 First fiscal year in the series	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged	€ 61,667 Bank debt 2026: € 61,667 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 30,135 Balance sheet total 2024: € 30,135 First fiscal year in the series	€ 169,279 Balance sheet total 2025: € 169,279 ▲ € 139,144 vs 2024 (€ 30,135) Unchanged	€ 515,161 Balance sheet total 2026: € 515,161 ▲ 204% vs 2025 (€ 169,279) Unchanged	▲ 204%

Key figures of Presscuff, fiscal years 2024 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to Presscuff?

What happened at Presscuff in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 23, 2026 New annual accounts for financial year 2026: loss of € 88,591. Source: NBB ↗
2025 Emiel Suijs stepped down as director. NBB
2024 SureFinance BV became a director. NBB
2024 Mabeco BV became a director. NBB
Apr 4, 2023 New establishment in Diepenbeek. KBO
2023 Emiel Suijs became a director. NBB
Apr 4, 2023 Start of the company according to the CBE. KBO

In short

From € 11,145 loss in 2024 to € 88,591 loss in 2026.

Original PDFs at the National Bank ↗

Management

SureFinance BV Mabeco BV

Presscuff

Behind Presscuff are SureFinance BV and Mabeco BV.

Directors

According to the 2026 annual accounts

SureFinance BV

Director · represented by Evert Van Meeuwen

since 2024

Mabeco BV

Director · represented by Benjamin De Vlam

since 2024

Emiel Suijs

Director

since 2023 · until 2025

Establishments

Establishment units

Physical locations of this company

Registered office

Agoralaan Abis

3590 Diepenbeek

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 14 companies are registered at this address.

All companies at this address →

Clinitude

€ 419,430 gross margin · 2025

FOx Biosystems

€ -763,895 gross margin · 2023

Highstar Engineering

€ -52,153 gross margin · 2025

IDEA FAMILY

€ -1,811 gross margin · 2026

BIOKEY

€ -16,079 gross margin · 2026

+9 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS presscuff.com

Technologies

ElementorFont AwesomeGoogle MapsNginxPHPWordPressjQueryjQuery UIlazysizes

Hosting & Email

Email provider

Self-hosted

Hosting

IONOS-AS This is the joint network for IONOS, Fasthosts, Arsys, 1&1 Mail and Media and 1&1 Telecom. Formerly known as 1&1 Internet SE., DE

Domain

presscuff.com

Registered

2019-05-19

Registrar

Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA

Expires

2026-05-19

Website info

HTTPS Ja

Languages EN

Features

Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Details

Company number: 0800.361.153
VAT number: BE 0800.361.153
Registered office: Agoralaan Abis, 3590 Diepenbeek
Names & denominations: Presscuff
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 April 2023
Peppol: Active · Active since 23 Dec 2025
Contact: presscuff.com [email protected]
Activities · NACE: Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden

View on CBE Public ↗ Annual accounts (NBB) ↗